This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Lg Electronics Inc.. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Dayeon Kang: Innovator in Cholesterol Measurement Technology
Introduction
Dayeon Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the measurement of cholesterol levels. With a total of 3 patents to his name, Kang is recognized for his innovative approaches to health diagnostics.
Latest Patents
One of Kang's latest patents is an "Apparatus and method for measuring cholesterol." This invention discloses an apparatus that effectively measures cholesterol using a small amount of blood. The apparatus includes a cartridge with an upper case that has a sample transferring membrane, which is movably coupled to a lower case containing a sample measuring membrane. It also features a cartridge accommodation unit, a memory for storing measurement settings, and a controller that aligns and contacts the membranes for sample transfer.
Another notable patent is a "Biochip including conductive particle and device for detecting target antigen comprising the same." This biochip allows for the effective detection of target antigens using minimal amounts, thereby reducing nonspecific detection signals and enabling the detection of amplified signals.
Career Highlights
Dayeon Kang is currently employed at LG Electronics Inc., where he continues to develop innovative technologies in the medical field. His work has garnered attention for its potential to improve health diagnostics and patient care.
Collaborations
Kang collaborates with talented individuals such as Seokjung Hyun and Jisu Kim, who contribute to his projects and research endeavors.
Conclusion
Dayeon Kang's contributions to cholesterol measurement technology and biochip development highlight his role as an influential inventor in the medical technology sector. His innovative patents reflect a commitment to advancing health diagnostics and improving patient outcomes.